Consultants have held several strikes over the past year, which has hobbled the NHS as it tries to grapple with financial constraints and backlogs caused by the coronavirus pandemic.
A survey by the Saskatchewan College of Pharmacy Professionals comes just weeks after its Ontario counterpart revealed the findings of a similar probe and announced a zero-tolerance stance on corporate pressures in pharmacy.
Amylyx Pharmaceuticals said it plans to study Relyvrio and and another experimental drug for several rare diseases, including Wolfram syndrome, which causes childhood diabetes and blindness.